tiprankstipranks
Fidia Spa (IT:FDA)
:FDA
Want to see IT:FDA full AI Analyst Report?

Fidia Spa (FDA) Price & Analysis

6 Followers

FDA Stock Chart & Stats

€0.12
>-€0.01(-6.28%)
At close: 4:00 PM EST
€0.12
>-€0.01(-6.28%)

Bulls Say, Bears Say

Bulls Say
Niche Product Portfolio & Multichannel DistributionFidia's focus on hyaluronic-acid therapies and its integrated model (R&D, manufacturing, direct sales plus third-party distributors) supports durable market access and scalability in orthopedics. Diversified distribution reduces concentration risk and helps sustain revenue across regions.
2025 Revenue ReboundA strong 2025 revenue recovery demonstrates underlying demand resilience and successful commercial execution. If sustained, this top-line momentum can provide a platform to stabilize margins, leverage fixed manufacturing capacity, and improve long-term profitability trends.
Improved Equity & Modest Reported 2025 DebtRestored equity and relatively low nominal debt in 2025 strengthen the capital base versus prior years, improving solvency headroom. This healthier balance sheet enhances the company's ability to fund R&D or commercial investments without immediate refinancing pressure.
Bears Say
Persistent Negative Operating And Free Cash FlowSustained operating and free cash flow deficits indicate structural cash-burn that depletes reserves and forces external funding or cost cuts. Over months this constrains reinvestment in growth, raises refinancing risk, and can impair the ability to sustain manufacturing or commercial initiatives.
Inconsistent And Generally Negative Operating ProfitabilityVolatile and frequently negative operating results undermine predictability of earnings and cash generation. Inconsistent margins limit capacity to build reserves during good periods and leave the company exposed to margin compression from cost or pricing shocks over the medium term.
Historical Leverage Volatility And Prior Negative EquityA history of negative equity and volatile leverage signals episodic balance-sheet stress and elevates refinancing and covenant risk. Even with 2025 improvement, prior capital instability raises concern that future profit or cash setbacks could quickly reintroduce solvency pressures.

Fidia Spa News

FDA FAQ

What was Fidia Spa’s price range in the past 12 months?
Fidia Spa lowest stock price was <€0.01 and its highest was €0.56 in the past 12 months.
    What is Fidia Spa’s market cap?
    Fidia Spa’s market cap is €9.75M.
      When is Fidia Spa’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Fidia Spa’s earnings last quarter?
      Currently, no data Available
      Is Fidia Spa overvalued?
      According to Wall Street analysts Fidia Spa’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Fidia Spa pay dividends?
        Fidia Spa pays a Annually dividend of €0.2 which represents an annual dividend yield of N/A. See more information on Fidia Spa dividends here
          What is Fidia Spa’s EPS estimate?
          Fidia Spa’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Fidia Spa have?
          Fidia Spa has 1,249,412,000 shares outstanding.
            What happened to Fidia Spa’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Fidia Spa?
            Currently, no hedge funds are holding shares in IT:FDA
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Company Description

              Fidia Spa

              Fidia S.p.A., together with its affiliated entities, focuses on engineering, producing, and supplying advanced high-speed milling systems and computerized numerical control (CNC) machines. Their product range also incorporates specialized milling heads, accompanying software, and various peripheral devices. Among these accessories, the HMS system is engineered for precise measurement and compensation of geometric errors in continuous or indexed bi-rotary heads and roto-tilting tables. The TMSC device accurately determines tool length and diameter, in addition to verifying its overall geometry. The K5 tracer provides a seamless solution for continuous scanning of three-dimensional surfaces. Other components include user-friendly pushbutton panels, XPower digital drives that control axis and spindle movement, and I/O Line input/output modules. Fidia's extensive software suite features ViMill, an anti-collision safeguard; HiMonitor, which tracks machine operational status; and Velocity 5, a system designed to optimize axis control, thereby enhancing machine performance. The HiMill computer-aided manufacturing (CAM) software is dedicated to the fabrication of dies, models, and aerospace components. An intuitive user interface is offered through the Isograph solution, while procedure-PRX provides tailored automation capabilities. The company serves critical sectors such as the automotive, aerospace, and power generation industries. Fidia's global presence covers Italy, the wider European continent, Asia, and both North and South America. Established in 1974, Fidia S.p.A. maintains its corporate headquarters in San Mauro Torinese, Italy.

              Fidia Spa (FDA) Earnings & Revenues

              Similar Stocks
              Company
              Price & Change
              Follow
              Biesse SPA
              Interpump Group SPA
              Tesmec S.p.A.
              Esautomotion SpA
              Marzocchi Pompe S.p.A.
              Popular Stocks